News

Looking for a new challenge? We are seeking a passionate Registered Nurse to support the development of New Zealand nursing procedures.  Lippincott is offering a part-time, work-from-home, flexible, freelance clinical editor role.   Please see job description attached.

We are writing to inform you that Sanofi, the supplier of isoniazid 100mg with rifampicin 150mg ( Rifinah ) tab, has advised of a supply issue due to delays with manufacturing. The current stock has the expiry date 30 November 2025.    Key messages: An alternative brand Rifamazid  has been listed (funded) from 1 December 2025. This is an unapproved medicine and as such needs to be prescribed and dispensed in line with section 29 of the Medicines Act. It is estimated it will be available to...

We want your feedback on a proposal to fund nitisinone for people with rare inherited metabolic disorders, including tyrosinemia type 1 and alkaptonuria. Nitisinone is currently funded through Pharmac’s Named Patient Pharmaceutical Assessment (NPPA) pathway. Under this proposal, it would be listed on the Pharmaceutical Schedule, making it easier for clinicians to prescribe and helping ensure ongoing supply in New Zealand. More information about the proposal is available here The consultation...

Coming up in CPD:  Tricky question... What do Ralph Stewart, Samantha Newman, Ben Chan, Hannah Giles, Ryan Paul, Buzz Burrell (and about 60 others) all have in common? Here's the answer   Post-partum hypertension; practical management WEBINAR 2 December: Dr Jamie Kitt, dual accredited Cardiology & General Internal Medicine Consultant on how to achieve optimal blood pressure control in women puerperium.  Register here   Cannabis-based products The March Medicines Amendment Act aims to enable...

This link  will take you to the proposal to enter into an agreement for sterilisation and decontamination equipment and associated consumable medical devices supplied by Steris New Zealand Limited (“Steris”). Steris’ range of medical devices are proposed to be listed on the Pharmaceutical Schedule under a Pharmac agreement from 1 February 2025. A list of products included in the proposal is attached .  Pharmac welcomes feedback on this proposal.  To provide feedback, please submit it in...

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 21 November 2025. It includes information on:  New updates Resolved Supply Issues Pharmac funding both Estradot and Estradiol TDP Mylan brands of oestradiol patches From 1 December 2025, the funded brands of oestradiol patches will be Estradiol TDP Mylan and Estradot. Everyone who uses funded oestradiol patches will need to use either of these brands. The following...